Aprilia’s parent company Piaggio has filed for a new trademark application in the United States to bring back the beloved ...

The OG Mille was powered by Rotax's mighty V990 engine. Is it time for a modern comeback?

Aprilia Tuono 457 is the smallest bike of its name in India Aprilia India has launched the Tuono 457 in the Indian market expanding the line of bikes based on the 457 platform. It comes at a ...

After making its debut at EICMA 2024 in Milan last November, Aprilia has finally launched ... shedding the quarter-fairing around the tank and headlamp for a more aggressive stance.

The long wait is over for those looking for a street-friendly version of the Aprilia RS457, as the Tuono 457 finally goes on sale in India. Priced at Rs 3.95 lakh, the Tuono 457 is slightly more ...

Aprilia has filed a new trademark in the US for the RSV1000 nomenclature, which has fuelled speculation about the comeback of ...

Unlike the Aprilia Tuono 660 and the Aprilia Tuono V4, the Tuono 457 doesn’t get the same quarter fairing and dual-headlight setup. This is a major break in design and styling and hardcore ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

GRAND RAPIDS, Mich. — As respiratory syncytial virus (RSV) cases surge, one family's harrowing experience highlights the importance of prevention. Emily and Joey Spadafore watched helplessly as ...

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

While reigning MotoGP champion’s Ducati have opted to keep their factory riders on last year’s GP24 powerplant, engine progress has been cited as one of the stand-out areas for Aprilia.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...